Skip to main content
. 2019 Oct 31;28(5):628–641. doi: 10.5607/en.2019.28.5.628

Table 1.

Patient description and tumor sample characteristics

Sample Sex Age Tumor type Location Sample Concentration (μg/μl) Sample volume (μl) Ki-67 index p53 Underlying disease
N1 M 66 Normal brain (human adult) Whole brain 4.47 150
N2 M 57 Normal brain (human adult) Whole brain 4.32 150
N3 M 82 Normal brain (human adult) Whole brain 4.89 150
Group 1 Meningioma, WHO grade I
1 M 61 Meningioma, meningothelial Parasagittal, right 28.62 110 <1% (−) Alcohol, smoking
2 F 64 Meningioma, fibrous Falx, right 29.13 200 1~2% (−) (−)
3 F 64 Meningioma, meningothelial CPA, right 23.01 100 1% (−) (−)
4 F 56 Meningioma, transitional Convexity, right 41.67 600 <1% 15% HTN, DM
5 F 74 Meningioma, transitional Falx, both 30.99 400 <1% 30% (−)
Group 2 Pituitary adenoma
6 F 51 Pituitary adenoma Pituitary gland 19.47 100 <1% 1% (−)
7 F 42 Pituitary adenoma, ACTH producing Pituitary gland 17.94 90 <1% 1% Cushing disease
8 M 51 Pituitary adenoma Pituitary gland 20.19 110 <1% (−) DM
9 M 38 Pituitary adenoma Pituitary gland 20.31 50 1% 1% (−)
10 F 53 Pituitary adenoma Pituitary gland 18.00 90 <1% 5% (−)

WHO, world health organization; CPA, cerebellopontine angle; HTN, hypertension; DM, diabetes mellitus; ACTH, adrenocorticotropic hormone.